Clinical Trials on Dermatitis, Irritant

Total 2994 results

Asana BioSciences

Completed

Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema

Chronic Hand Dermatitis

United States, Canada
Relife Italia S.r.l.

Completed

Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis. (DRESDA)

Radiodermatitis | Dermatitis, Radiation-Induced

Italy
University Hospital, Limoges

Completed

Skin Protection During Radiotherapy in Patients With Breast Cancer (EVOSKIN)

Radiation Dermatitis

France
M.D. Anderson Cancer Center

Completed

Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients

Radiation Dermatitis

United States
Clinuvel Pharmaceuticals Limited

Completed

Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)

Polymorphic Light Eruption
Noveome Biotherapeutics, formerly Stemnion

Completed

Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

Radiation-induced Dermatitis

United States
Medical University of Graz

Completed

Calcipotriol and Polymorphic Light Eruption

Polymorphic Light Eruption

Austria
University of Zurich
University of Bonn

Recruiting

Prospective Longitudinal Observational Research in Atopic Dermatitis (ProRaD)

Asthma | Atopic Dermatitis | Atopic Dermatitis and Related Conditions

Switzerland
Novartis Pharmaceuticals

Completed

Safety and Efficacy of DNK333 in Atopic Dermatitis Patients

Pruritus in Patients With Atopic Dermatitis

Germany
Integrative Skin Science and Research
Codex Labs

Recruiting

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

Rosacea | Seborrheic Dermatitis | Melasma | Acne

United States
Welcare Industries SpA

Recruiting

Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel. (JALOSOME-01)

Radiation-induced Dermatitis

Italy
Medical University of Graz

Recruiting

Skin Microbiome and Polymorphic Light Eruption (PLE_microbio)

Polymorphic Light Eruption

Austria
Herbarium Laboratorio Botanico Ltda

Completed

Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray

Sensitivity, Contact

Brazil
Pfizer

Completed

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Stasis Dermatitis

United States
Herbarium Laboratorio Botanico Ltda

Completed

Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization

Sensitivity, Contact

Brazil
UNION therapeutics

Completed

Sensitization Study of ATx201 in Healthy Volunteers

Sensitivity, Contact

United States
Medical University of Graz
Austrian Science Fund (FWF)

Terminated

Vitamin D Supplementation in Polymorphic Light Eruption (VitD-PLE_2012)

Polymorphic Light Eruption

Austria
Medical University of Graz

Completed

Sunscreen and After-sun-lotion Protection in Polymorphic Light Eruption

Polymorphic Light Eruption

Austria
Massachusetts General Hospital

Active, not recruiting

Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury

Chronic Radiation Dermatitis

United States
Sanofi

Recruiting

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Monotherapy Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (ESTUARY)

Dermatitis Atopic

United States
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Dermatitis Atopic

Argentina, Japan, China, Czechia, Spain, United States, South Africa, United Kingdom, Denmark, Sweden, Turkey
Sanofi
Regeneron Pharmaceuticals

Recruiting

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis (PELISTAD-EX2)

Dermatitis Atopic

United States, United Kingdom
Sanofi

Recruiting

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (ATLANTIS)

Dermatitis Atopic

Italy, United Kingdom, Argentina, France, Chile, Czechia, Germany, Japan, Spain, China, Netherlands, Brazil, Canada, Denmark, Korea, Republic of, South Africa, Taiwan, Poland, India, Mexico
Sanofi

Recruiting

A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)

Dermatitis Atopic

United States
Sanofi

Recruiting

Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)

Dermatitis Atopic

Norway, Spain, Argentina, Israel, Greece, United States, Australia, Brazil, Canada, China, Colombia, Denmark, France, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation
Sanofi
Regeneron Pharmaceuticals

Completed

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis (PELISTAD)

Dermatitis Atopic

United States, United Kingdom
Azidus Brasil

Withdrawn

Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis

Dermatitis

Brazil
GlaxoSmithKline

Completed

A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis

Skin Diseases

China
LEO Pharma

Completed

LEO 29102 Single and Multiple Dose Study by Dermal Application

Atopic Dermatitis

United Kingdom
Istanbul Bilgi University
Istanbul University - Cerrahpasa (IUC)

Enrolling by invitation

Effects of Critical Patient-centered Skin Care Protocol

Pressure Injury | Incontinence-associated Dermatitis

Turkey
University of Maryland, Baltimore
Integra LifeSciences Corporation

Completed

MediHoney for Radiation Dermatitis

Breast Cancer | Radiation Dermatitis

United States
Scotiaderm

Not yet recruiting

Efficacy of Cream for Moisture Associated Skin Damage From Fecal Incontinence and/or Diarrhea (Survey)

Incontinence-associated Dermatitis | Moisture Associated Skin Damage (MASD) (E.G., Incontinence-Associated Dermatitis [IAD], Perspiration, Drainage) | Fecal Incontinence Incontinence-associated Dermatitis
Vanda Pharmaceuticals

Completed

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

Treatment-resistant Pruritus Associated With Atopic Dermatitis

Germany
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids (SHORE)

Dermatitis Atopic

Japan, Chile, Canada, Argentina, United States, Turkey, China
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 1)

Dermatitis Atopic

Israel, Chile, Australia, United States, France, Canada, Germany, Korea, Republic of, Taiwan, China
Sanofi

Recruiting

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo (HYDRO)

Dermatitis Atopic

Canada, United States
Centre Hospitalier Universitaire de la Réunion

Not yet recruiting

HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers (HypnoDA)

Dermatitis

Réunion
Sanofi

Recruiting

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials (RIVER-AD)

Dermatitis Atopic

Canada, United States, Australia, Bulgaria, Czechia, Germany, Hungary, Japan, Poland, Spain, Taiwan, United Kingdom
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) (GLOBOSTAD)

Dermatitis Atopic

Spain, Czechia, Italy, Israel, Argentina, Australia, Austria, Belgium, Colombia, Finland, France, Greece, Japan, Kuwait, Mexico, Netherlands, Norway, Portugal, Russian Federation, Saudi Arabia, Taiwan, United Arab Emirates
Hordinsky, Maria K., MD

Terminated

Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients

Dermatitis

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis

Dermatitis

United States
Mayo Clinic

Active, not recruiting

Determining Molecular Drivers of Radiation Dermatitis

Breast Cancer

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%

Dermatitis, Seborrheic
Eli Lilly and Company

Not yet recruiting

Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis

Atopic Dermatitis

United States
Oneness Biotech Co., Ltd.

Not yet recruiting

Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
Apogee Therapeutics, Inc.

Recruiting

A Study Evaluating APG777 in Atopic Dermatitis

Atopic Dermatitis

United States, Canada
AbbVie

Recruiting

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)

Atopic Dermatitis

United States
Instituto de Investigación Hospital Universitario...

Recruiting

Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models

Atopic Dermatitis

Spain
Technoderma Medicines Inc.
Therapeutics, Inc.

Recruiting

Study of TDM-180935 in Atopic Dermatitis Patients

Atopic Dermatitis

United States
Hangzhou Yirui Pharmaceutical Technology Co., Ltd

Not yet recruiting

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States

3

Subscribe